Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Moore

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 1, 1995
Role of tryptase in immediate cutaneous responses in allergic sheepJ F Molinari, W R Moore, J Clark, et al.
Antimicrobial Agents and Chemotherapy|January 22, 2015
VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig modelE P Garvey, W J Hoekstra, W R Moore, et al.
Biochemistry|April 19, 2000
A novel approach to serine protease inhibition: kinetic characterization of inhibitors whose potencies and selectivities are dramatically enhanced by Zinc(II)J W Janc, J M Clark, R L Warne, et al.
Journal of Medicinal Chemistry|September 18, 1992
N-(1-oxododecyl)-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol: a potent competitive inhibitor of 2,3-oxidosqualene cyclaseM W Wannamaker, P P Waid, W A Van Sickle, et al.
American Journal of Respiratory and Critical Care Medicine|December 1, 1995
Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheepJ M Clark, W M Abraham, C E Fishman, et al.
Nature|February 19, 1998
Design of potent selective zinc-mediated serine protease inhibitorsB A Katz, J M Clark, J S Finer-Moore, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzymeA G S Warrilow, C M Hull, J E Parker, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 1, 1995
Role of tryptase in immediate cutaneous responses in allergic sheepJ F Molinari, W R Moore, J Clark, et al.
Antimicrobial Agents and Chemotherapy|January 22, 2015
VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig modelE P Garvey, W J Hoekstra, W R Moore, et al.
Biochemistry|April 19, 2000
A novel approach to serine protease inhibition: kinetic characterization of inhibitors whose potencies and selectivities are dramatically enhanced by Zinc(II)J W Janc, J M Clark, R L Warne, et al.
Journal of Medicinal Chemistry|September 18, 1992
N-(1-oxododecyl)-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol: a potent competitive inhibitor of 2,3-oxidosqualene cyclaseM W Wannamaker, P P Waid, W A Van Sickle, et al.
American Journal of Respiratory and Critical Care Medicine|December 1, 1995
Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheepJ M Clark, W M Abraham, C E Fishman, et al.
Nature|February 19, 1998
Design of potent selective zinc-mediated serine protease inhibitorsB A Katz, J M Clark, J S Finer-Moore, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzymeA G S Warrilow, C M Hull, J E Parker, et al.
Pageof 3